Lopes Ana, Pereira Carla, Almeida Adelaide
Department of Biology and CESAM, University of Aveiro, Campus Universitário de Santiago, 3810-193 Aveiro, Portugal.
Microorganisms. 2018 Dec 5;6(4):125. doi: 10.3390/microorganisms6040125.
The emergence of antibiotic resistance in bacteria is a global concern. The use of bacteriophages (or phages) alone or combined with antibiotics is consolidating itself as an alternative approach to inactivate antibiotic-resistant bacteria. However, phage-resistant mutants have been considered as a major threat when phage treatment is employed. is one of the main responsible pathogens for moderate and serious infections in hospital and community environments, being involved in the rapid evolution of fluoroquinolones and third-generation cephalosporin resistance. The aim of this study was to evaluate the effect of combined treatments of phages and antibiotics in the inactivation of . For this, ciprofloxacin at lethal and sublethal concentrations was added at different times (0, 6, 12 and 18 h) and was tested in combination with the phage ELY-1 to inactivate . The efficacy of the combined treatment varied with the antibiotic concentration and with the time of antibiotic addition. The combined treatment prevented bacterial regrowth when the antibiotic was used at minimum inhibitory concentration (MIC) and added after 6 h of phage addition, causing less bacterial resistance than phage and antibiotic applied alone (4.0 × 10 for the combined treatment, 3.9 × 10 and 3.4 × 10 for the antibiotics and the phages alone, respectively). Combined treatment with phage and antibiotic can be effective in reducing the bacterial density and it can also prevent the emergence of resistant variants. However, the antibiotic concentration and the time of antibiotic application are essential factors that need to be considered in the combined treatment.
细菌中抗生素耐药性的出现是一个全球关注的问题。单独使用噬菌体(或噬菌)或与抗生素联合使用正逐渐成为一种使抗生素耐药细菌失活的替代方法。然而,当采用噬菌体治疗时,噬菌体抗性突变体被认为是一个主要威胁。是医院和社区环境中中度和重度感染的主要致病病原体之一,参与氟喹诺酮类和第三代头孢菌素耐药性的快速演变。本研究的目的是评估噬菌体和抗生素联合治疗对失活的效果。为此,在不同时间(0、6、12和18小时)添加致死和亚致死浓度的环丙沙星,并与噬菌体ELY-1联合测试以失活。联合治疗的效果随抗生素浓度和抗生素添加时间而变化。当抗生素以最低抑菌浓度(MIC)使用并在添加噬菌体6小时后添加时,联合治疗可防止细菌再生长,产生的细菌耐药性比单独使用噬菌体和抗生素时少(联合治疗为4.0×10,单独使用抗生素和噬菌体时分别为3.9×10和3.4×10)。噬菌体和抗生素联合治疗可有效降低细菌密度,还可防止耐药变体的出现。然而,抗生素浓度和抗生素应用时间是联合治疗中需要考虑的重要因素。